SciELO - Scientific Electronic Library Online

 
vol.91 número4Terapia antibiótica intravenosa posterior a apendicectomía por laparoscopia en apendicitis aguda complicada: la respuesta clínica del paciente es la clavePredicción de la proporción de aspartato aminotransferasa a alanina aminotransferasa (De Ritis) para detectar necrosis intestinal en pacientes con hernia inguinal incarcerada índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Cirugía y cirujanos

versión On-line ISSN 2444-054Xversión impresa ISSN 0009-7411

Resumen

XU, Ziyang et al. Prognostic analysis and outcome of hilar cholangiocarcinoma after radical resection: a retrospective study. Cir. cir. [online]. 2023, vol.91, n.4, pp.486-493.  Epub 30-Oct-2023. ISSN 2444-054X.  https://doi.org/10.24875/ciru.22000589.

Objectives:

The predictive factors affecting the survival of hilar cholangiocarcinoma (HC) are ambiguous. This study aimed to identify the predictors and recurrence patterns of HC.

Methods:

A retrospective analysis of the clinicopathological findings of 126 patients with HC from 2009 to 2019 was performed.

Results:

The proportion of Bismuth I and II HC in the recurrence group was higher than that in the non-recurrence group (p < 0.01). The recurrence group had poorer tumor differentiation, a more advanced N stage, and a higher incidence of perineural invasion compared with the non-recurrence group. N stage and tumor differentiation were independently associated with disease-free and overall survival of patients (p < 0.01). Bile duct resection (BDR) combined with hepatectomy was more favorable to disease-free and overall survivals than BDR alone in Bismuth I and II HC, although p values were marginal (p = 0.072 and p = 0.045). A higher proportion of patients in the non-recurrence group underwent BDR combined with hepatectomy than that in the recurrence group (p < 0.01).

Conclusions:

N stage and tumor differentiation are the two independent predictors of patient survival. BDR combined with hepatectomy is recommended for patients with Bismuth I and II hilar cholangiocarcinoma.

Palabras llave : Hilar cholangiocarcinoma; Bismuth classification; Survival; Bile duct resection; Hepatectomy.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )